References
- Caniggia A., Vattimo A. Kinetics of 99m-technetiumtin methylene diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism. Calcif. Tissue Int. 1980; 30: 5
- Christensen S. B., Krogsgård O. W. Localization of Tc-99m MDP in epiphyseal growth plates of rats. J. nucl. Med. 1981; 22: 237
- Fogelman I., Bessent R. G., Beastall G., Boyle I. T. Estimation of skeletal involvement in primary hyperparathyroidism. Ann. Int. Med. 1980; 92: 65
- Fogelman I., Bessent R. G., Citrin D. L., Boyle I. T., Greig W. R. The use of whole body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease. J. nucl. Med. 1978; 19: 270
- Fogelman I., Bessent R. G., Cohen N. H., Hart D. M., Lindsay R. Skeletal uptake of diphosphonate: method for prediction of postmenopausal osteoporosis. Lancet 1980; ii: 667
- Johansson L., Mattson S., Nosslin B. Stråldoser från radioaktive ämnen i medicinskt bruk. Information till sjukhusens isotopkommiteer. 2: a omarbetade upplagen 1981, Statens stråiskyddsinstitut. Box 60204, 10401 Stockholm
- Martin W., Fogelman I., Bessent R. G. Measurements of 24-hour whole body retention of Tc-99m HEDP by a gamma camera. J. nucl. Med. 1981; 22: 542
- Mautalen C. A. Orcadian rhythm of urinary total and free hydroxyproline excretion and its relation to creatinine excretion. J. Lab. clin. Med. 1970; 1: 11
- Niell H. B., Palmieri G. M., Neely C. L., McDonald M. W. Postabsorptive urinary hydroxyproline test in patients with metastatic bone disease from breast cancer. Arch. int. Med. 1981; 141: 1471
- Rosenthall L., Arzoumanian A. Total body retention measurements of Tc-99m MDP using a simple detector. Clin. nucl. Med. 1983; 8: 210